Auto-immune hepatitis associated with fibrate treatment;Hepatites d'allure auto-immune induites par les fibrates

Gastroenterologie Clinique et Biologique

Volumn 22, Issue 5, 1998, Pages 525-529

  Ganne Carrié, Nathalie ^a   De Leusse, Antoine ^a   Guettier, Catherine ^a   Castera, Laurent ^a   Levecq, Hervé ^a,b   Bertrand, Henri Joseph ^a,c   Plumet, Yves ^d   Trinchet, Jean Claude ^a   Beaugrand, Michel ^a  

^a HÔPITAL JEAN VERDIER   (France)

^b CENTRE HOSPITALIER   (France)

^c Clinique des Jockeys   (France)

^d CENTRE HOSPITALIER DE TROYES   (France)

Author keywords

Auto immune hepatitis; Fibrates; Toxic hepatitis

Indexed keywords

AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; CIPROFIBRATE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; IMMUNOGLOBULIN; ANTILIPEMIC AGENT; CLOFIBRIC ACID; DRUG DERIVATIVE;

AGED; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERGAMMAGLOBULINEMIA; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER NECROSIS; MALE; RELAPSE; TOXIC HEPATITIS; AUTOIMMUNE DISEASE; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; MIDDLE AGED;

AGED; ANTILIPEMIC AGENTS; AUTOIMMUNE DISEASES; CLOFIBRIC ACID; FEMALE; HEPATITIS, TOXIC; HUMANS; MALE; MIDDLE AGED; PROCETOFEN;

EID: 0032057209     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Manns MP, Kruger M. Immunogenetics of chronic liver diseases. Gastroenterology 1994;106:1676-97.
2. McFarlane IG. Auto-immunity and hepatotropic viruses. Semin Liver Dis 1991;11:223-9.
3. Vento S, Garofana T, Di Perri G, Dolci L, Concia E, Bassetti D. Identification of hepatitis A virus as a trigger for auto-immune chronic hepatitis type I in susceptible individuals. Lancet 1991;337:1183-6.
4. Laskus T, Slusarczyk J. Auto-immune chronic active hepatitis developing after acute type B hepatitis. Dig Dis Sci 1989, 34:1294-7.
5. Vento S, Guella L, Mirandola F, Cainelli F, Di Perri G, Solbiati M et al. Epstein-Barr virus as a trigger for auto-immune hepatitis in susceptible individuals. Lancet 1995;346:608-9.
6. Homberg JC, Abuaf N, Helmy-Khalil S, Biour M, Poupon R, Islam S, et al. Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology 1985;5:722-7.
7. Van Pelt F, Straub P, Manns MP. Molecular basis of drug-induced immunological liver injury. Semin Liver Dis 1995;15:283-300.
8. Sterling MJ, Kane M, Grace ND. Pemoline-induced auto-immune hepatitis. Am J Gastreoenterol 1996;91:2233-4.
9. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5
10. c mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables. Gastroenterol Clin Biol 1997;21; 660-96.
11. Lclouch S, Pelletier G, Sinico M, Ducreux M, Etienne JP. Hépatite aiguë pseudo-angiocholitique au fénofibrate. Gastroenterol Clin Biol 1992;16:597-9.
12. Couzigou P, Boutillier P, Boisseau C, Faucher P, De Mascarel A, Amouretti M, et al. Hépatite médicamenteuse au fénofibrate. Thérapie 1980;35:403.
13. Massen H, Furet Y. Hépatite au fénofibrate. Cah Anesthesiol 1986;34:249-50.
14. Rigal F, Furet Y, Autret E, Breteau M. Hépatite mixte sévère au fénofibrate. Revue de la littérature à propos d'un cas. Rev Med Interne 1989;10:65-7.
15. Roberts CW. Safety of fenofibrate. US and worldwide experience. Cardiology 1989;76:169-79.
16. Lepicard A, Mallat A, Zafrani ES, Dhumeaux D. Atteinte chronique des canaux biliaires interlobulaires induite par le fénofibrate. Gastroenterol Clin Biol 1994;18:1033-5.
17. Migneco G, Mascarella A, La Ferla A, Attianese R. Epatite da clofibrato. Minerva Med 1986;77:799-800.
18. Bernard PH, Lamouliatte H, Le Bail B, Bioulac-Sage P, Quinton A, Balabaud C. Hépatite chronique active associée à des anticorps anti-noyau induite par le fénofibrate. Gastroenterol Clin Biol 1994;18:1048-9.
19. Czaja AJ. Natural history, clinical features and treatment of auto-immune hepatitis. Semin Liver Dis 1984;4:1-12.
20. Johnson PJ, McFarlane IG, Alvarez F, Bianchi FB, Burroughs A, Chapman RW et al. Meeting report. International auto-immune hepatitis group. Hepatology 1993;18:998-1005.
21. Bartles JR, Khuon S, Lin XH, Zhang LQ, Reddy JK, Rao MS, et al. Peroxysome proliferator-induced alterations in the expression and modification of rat hepatocyte plasma membrane proteins. Cancer Res 1990;50:669-76.
22. Blane GF, Pinaroli F. Fénofibrate: étude de toxicologie animale en rapport avec les effets secondaires chez les malades. Nouv Presse Med 1980;9:3737-46.
23. Cohen AJ, Grasso P. Review of the hepatic response to hypolipidemic drugs in rodents and assessment of its toxicological significance to men. Food Cosmet Toxicol 1981;19:585-605.